...
首页> 外文期刊>Melanoma research >Melanoma of unknown primary site: A 33-year experience at the Turin Melanoma Centre
【24h】

Melanoma of unknown primary site: A 33-year experience at the Turin Melanoma Centre

机译:主要部位未知的黑色素瘤:在都灵黑色素瘤中心有33年的工作经验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Unknown melanoma occurs as metastasis to skin, nodes or viscera, without a detectable cutaneous primary tumour. We reviewed our database of 4881 melanoma patients, diagnosed and followed up prospectively for a 33-year period. We identified 93 cases of metastatic melanoma without evidence of primary; however, five of these patients had a history of a previous excision of a presumed benign lesion without histological examination and were excluded from analyses. At diagnosis, metastases were cutaneous in 35.3% of cases, nodal in 43.2% and visceral in 17% of cases; in 4.5% of patients, both skin and nodes were involved. In all cases, clinical inspection and staging procedures performed at diagnosis of metastatic disease failed to identify a primary melanoma. In 11 cases (11.8%), extensively regressed pigmented lesions (without evidence of melanoma cells at the histological examination) were documented; moreover, we identified in our series five patients with unknown primary affected by vitiligo. The 5-year and 10-year overall survival rates were 49.6 and 41.4%, respectively, with a median of 4.9 years. The 5-year and 10-year time to progression rates were 39.4 and 32.3%, respectively, with a median of 2.3 years. Survival was longer in females and showed significant differences among patients with skin, lymph node or visceral involvement at diagnosis. In melanoma patients, unknown primary represents a not so rare event, with an uncertain origin. We confirmed the relatively good prognosis of unknown primary melanoma patients, a fact that has to be taken into consideration for their management.
机译:未知的黑色素瘤发生在皮肤,淋巴结或内脏的转移,没有可检测到的皮肤原发性肿瘤。我们回顾了4881名黑色素瘤患者的数据库,对其进行了33年的前瞻性诊断和随访。我们鉴定了93例无原发性转移性黑色素瘤的病例。然而,这些患者中有5例曾有过先前切除的假定良性病变的病史,而没有进行组织学检查,因此被排除在分析之外。在诊断时,皮肤转移为35.3%,淋巴结转移为43.2%,内脏转移为17%。在4.5%的患者中,皮肤和淋巴结均受累。在所有情况下,在诊断转移性疾病时进行的临床检查和分期程序均未能鉴定出原发性黑色素瘤。在11例(11.8%)的病例中,发现了广泛消退的色素性病变(在组织学检查中没有发现黑色素瘤细胞的证据)。此外,我们在我们的系列中确定了5名原发性白癜风患者。 5年和10年总生存率分别为49.6%和41.4%,中位数为4.9年。 5年和10年的进展时间分别为39.4%和32.3%,中位数为2.3年。女性的生存期更长,并且在诊断时有皮肤,淋巴结或内脏受累的患者之间存在显着差异。在黑色素瘤患者中,原发性不明代表的事件并不罕见,起源不确定。我们证实了未知的原发性黑色素瘤患者的相对较好的预后,这一事实在他们的治疗中必须予以考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号